Substituted amino acids as erythropoietin mimetics

Details Substituted amino acids as erythropoietin mimetics Substituted amino acids as erythropoietin mimetics

2006-12-26

2006-12-26

Davis, Brian (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S354000, C514S355000, C514S444000, C514S471000, C514S533000, C514S535000, C514S539000, C514S562000, C514S563000, C514S567000, C514S620000, C549S487000, C549S077000, C560S039000, C560S012000, C560S013000, C560S042000, C562S444000, C562S448000, C562S430000, C562S435000, C564S157000, C546S225000, C546S316000, C546S323000

Reexamination Certificate

active

07153869

ABSTRACT:
This invention relates to a series of substitituted amino acids of Formula Ipharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention are small molecules which bind to the erythropoietin receptor and compete with the natural ligand for binding to this receptor.

REFERENCES:
patent: 6310078 (2001-10-01), Connolly et al.
patent: 6750369 (2004-06-01), Connolly et al.
Database CAPLUS on STN, Acc. No. 1984:68019, JP 58150562 (Sep. 7, 1983) (abstract).
Database CAPLUS on STN, Acc. No. 1979:23639, Takemura et al., Yakugaku Zasshi (1978), 98(7), p. 869-879 (abstract).
Database CAPLUS on STN, Acc. No. 1978:510293, Halstrom et al., Journal of Chemical Research, Synopses (1978), (2), p. 80-81 (abstract).
Bonjoch, J. et al., “Synthesis of Enantiopure (2R, 3aS, 7aS)-2-Ethylocatahydroindol-6-One and its Fischer Indolization”,Tetrahedron: Assymmetry, 1997, 8(18), 3143-3151.
Foucaud, A. et al., “Preparation d'amines Allyliques a Partir D'acyloxy-3-Methylene-2 Propionates de Methyle Substitutes en 3 Par Un Groupement Aromatique ou Heteroaramatique”,Manuscrit Recu Le, 1989, 24-01, 22-03.
Hoffman, R. et al., An Improved Enantiospecific Synthesis of Statine and Statine Analogs via 4-(N, N-Dibenzylamino)-3-Keto Esters,J. Org. Chem., 1997, 62, 2292-2297.
Julia, M. et al., “Cyclisations par Substitution Aromatique Radicalaire. I. Synthesis de Composes Tetraliniques Par Addiction-Cyclisation Radicalaire”,Manuscript Recu Le, 26.2.68.
Kawasa, M., “Unusual Reactions of Secondary Amino Acids with Trifluroacetic Anhydride: A Novel Access to α-Trifluoromethylated Acyloins”,Tetrahedron Letters, 1994, 35(1), 149-152.
Koji, N. et al., CODEN:JKXXAF. 52024765 770225 Showa. Patent written in Japanese. Application: JP 75-100635 750821 CAN, 87:68150.
Kubota, Y. et al., “A Specific Inhibitor of Phosphatidy,inositol-3-Kinase, Inhibits Erythopoietin-Induced Erythroid Differentation of K562 Cells”,Leukemia, 1996, 10, 720-726.
Li, J.P. et al., “Activation of Cell Growth by Binding of Friend Spleen Focus-Forming Virus gp55 Glycoprotein to the Erythropoietin Receptor”,Letters to Nature, Feb. 22, 1990, 343.
Oppolzer, W. et al., “Stereoselective Synthesis of Benz[f] Isoindoline-Derivatives by Intrmolecular Cycloadditions of Styrenes to Olefins”,Helvetica Chimica Acta, 1976, 59(4), 121.
Takeda Chemical Industries. Ltd., Japan, “N-Substituted Glycine Derivatives”, Jpn. Kokai, Tokkyo Koho, 10 pp. CODEN:JKXXAF. JP 58150562 A2 83907 Showa. Patent Written in Japanese. Application: JP 82-34296 820303 CAN 100:68019.
Tsatsas, MG., “Sur Quelques Chloracetamides”,manuscript Recu Le, 8.3.68.
White, W. et al., The Ortho—claisen Rearrangement. Iv. The Rearrangement of X-Cinnalyl α-Tolyl Ethers.,The Department of Chemistry, The Ohio State University, Columbus 10, Ohio, Nov. 28, 1960.
Database CAPLUS on STN, Acc No. 1996:461584, Wrighton, et al., “Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin”,Science, 1996, 273, 5274.
Database CAPLUS on STN, Acc No. 1994:270195,Heterocycles, 1993, 36(11), 2441-2444.
Database CAPLUS on STN, Acc No. 1993:29833, HIRANO, JP 04143751.
Database CAPLUS on STN, Acc No. 1993:580342, Lagu, et al.,J. Org. Chem, 1993, 58(16), 4191-4193.
Database CAPLUS on STN, Acc No. 1997-72585, Malyshev, et al., “Limitation of Lipid Peroxidation and Prevention of Stress Damage to the Heart with Glycine Derivatives”,Eksp. Klin. Farmakol, 1996, 59(5), 23-25.

Affiliated with

Also associated with

Rating

Substituted amino acids as erythropoietin mimetics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted amino acids as erythropoietin mimetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted amino acids as erythropoietin mimetics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3691973